Identifiants & Marche
Ticker
TCBP
ISIN
US87807D4007
CIK
0001872812
Bourse
NASDAQ
Devise
USD
Entreprise
Pays
GB
Siege
N/A
Fondee
N/A
Description
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.